FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,414,000 | +26.0% | 72,273 | 0.0% | 0.53% | -32.8% |
| Q3 2019 | $1,122,000 | -90.8% | 72,273 | -88.0% | 0.79% | -81.4% |
| Q2 2019 | $12,223,000 | -0.2% | 602,096 | -13.6% | 4.24% | -21.7% |
| Q1 2019 | $12,248,000 | +36.9% | 697,096 | 0.0% | 5.42% | +25.2% |
| Q4 2018 | $8,944,000 | – | 697,096 | – | 4.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |